DuPont de Nemours, Inc.

DD Basic Materials Specialty Chemicals

DuPont de Nemours, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.8 billion, up 1.93% from fiscal 2024.

Revenue
+4.07%
EPS
+207.8%
Free cash flow
+36.7%
Total debt
−65.2%

Quarter to September 2026, against a year earlier

147.18 2.25 +1.55%
Market cap
$19.2B
P/E
64.2×
Fwd P/E
26.3×
Dividend yield
1.65%
F-score
6/9
Altman Z
0.35
Beneish M
−2.05
Dividend safety
24/100

DuPont de Nemours, Inc. 10-Q filed Nov 3, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed · accepted 2:27 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Aug 4, 2026: 16 added · 3 removed · 34 modified; 23 with only figures updated

  1. Modified · Aramids Divestiture

    On April 1, 2026, DuPont completed the sale of the Aramids business (the "Aramids Divestiture") to Arclin, a portfolio company of an affiliate of TJC LP, ("TJC"), in return for pre-tax cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a note receivable in the principal amount of $300 million (the "Aramids Note Receivable") and a non-controlling common equity interest (the "Aramids Equity Consideration"), valued at $325 million in the New Arclin U.S. Holding CorpARC Falcon Holdings LP ("Arclin") that holds the Arclin global materials business and the Aramids business being divested. The financial results of the Aramids divested business are reflected in DuPont's interim Consolidated Financial Statements as discontinued operations, along with comparative periods.